Stephanie M Downs-Canner (Stephanie Downs-Canner)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Positive Breast Cancer

Coronary Artery Bypass

Top Venues

Annals of surgical oncology

NPJ breast cancer

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Sara P Myers, Stephanie M Downs-Canner
ASO Author Reflections: Immune-Related Adverse Events During Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer May Influence Time to Adjuvant Radiation. Annals of surgical oncology (2024)
Sara P Myers, Varadan Sevilimedu, V Morgan Jones, Nour Abuhadra, Giacomo Montagna, George Plitas, Monica Morrow, Stephanie M Downs-Canner
Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer. Annals of surgical oncology (2024)
Sara P Myers, Stephanie M Downs-Canner
ASO Author Reflections: Immune-Related Adverse Events During Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer May Influence Time to Adjuvant Radiation. Annals of surgical oncology 31 (8) (2024)
Sara P Myers, Varadan Sevilimedu, V Morgan Jones, Nour Abuhadra, Giacomo Montagna, George Plitas, Monica Morrow, Stephanie M Downs-Canner
Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer. Annals of surgical oncology 31 (8) (2024)
Sara P Myers, Varadan Sevilimedu, V Morgan Jones, Nour Abuhadra, Giacomo Montagna, George Plitas, Monica Morrow, Stephanie M Downs-Canner
ASO Visual Abstract: Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer. Annals of surgical oncology 31 (8) (2024)
Sara P Myers, Varadan Sevilimedu, V Morgan Jones, Nour Abuhadra, Giacomo Montagna, George Plitas, Monica Morrow, Stephanie M Downs-Canner
Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer. Annals of surgical oncology 31 (8) (2024)
Sara P Myers, Stephanie M Downs-Canner
ASO Author Reflections: Immune-Related Adverse Events During Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer May Influence Time to Adjuvant Radiation. Annals of surgical oncology 31 (8) (2024)
Sara P Myers, Varadan Sevilimedu, V Morgan Jones, Nour Abuhadra, Giacomo Montagna, George Plitas, Monica Morrow, Stephanie M Downs-Canner
ASO Visual Abstract: Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer. Annals of surgical oncology (2024)
Sara P Myers, Varadan Sevilimedu, V Morgan Jones, Nour Abuhadra, Giacomo Montagna, George Plitas, Monica Morrow, Stephanie M Downs-Canner
ASO Visual Abstract: Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer. Annals of surgical oncology 31 (8) (2024)
Nicole Knape, Ji-Hye Park, Chris B Agala, Philip Spanheimer, Monica Morrow, Stephanie M Downs-Canner, Xavier L Baldwin
ASO Visual Abstract: Can We Forego Sentinel Lymph Node Biopsy in Women ≥50 Years of Age with Early-Stage Hormone Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer? Annals of surgical oncology (2022)
Selena J An, Emilie D Duchesneau, Paula D Strassle, Katherine Reeder-Hayes, Kristalyn K Gallagher, David W Ollila, Stephanie M Downs-Canner, Philip M Spanheimer
Pathologic complete response and survival after neoadjuvant chemotherapy in cT1-T2/N0 HER2+ breast cancer. NPJ breast cancer 8 (1) (2022)
Nicole Knape, Stephanie M Downs-Canner, Xavier L Baldwin
ASO Author Reflections: Using Population-Level Data to Individualize Surgical Decision-Making and Reduce Morbidity. Annals of surgical oncology (2022)
Katherine A Hrebinko, Cindy L Bryce, Stephanie M Downs-Canner, Emilia J Diego, Sara P Myers
Cost-effectiveness of Choosing Wisely guidelines for axillary observation in women older than age 70 years with hormone receptor-positive, clinically node-negative, operable breast tumors. Cancer 128 (12) (2022)
Alina M Hamilton, Amber N Hurson, Linnea T Olsson, Andrea Walens, Joseph Nsonwu-Farley, Erin L Kirk, Yara G Abdou, Stephanie M Downs-Canner, Jonathan S Serody, Charles M Perou, Benjamin C Calhoun, Melissa A Troester, Katherine A Hoadley
The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer Patients. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (7) (2022)
Kathleen A Iles, Mya L Roberson, Philip M Spanheimer, Kristalyn K Gallagher, David W Ollila, Paula D Strassle, Stephanie M Downs-Canner
The impact of age and nodal status on variations in oncotype DX testing and adjuvant treatment. NPJ breast cancer 8 (1) (2022)
Nicole Knape, Ji-Hye Park, Chris B Agala, Philip Spanheimer, Monica Morrow, Stephanie M Downs-Canner, Xavier L Baldwin
Can We Forgo Sentinel Lymph Node Biopsy in Women Aged ≥ 50 Years with Early-Stage Hormone-Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer? Annals of surgical oncology (2022)
Kathleen Iles, Paula D Strassle, Chris B Agala, Julia Button, Stephanie M Downs-Canner
Surgical Axillary Staging Before Neoadjuvant Chemotherapy: Who Gets It and Why We Should Avoid It. Annals of surgical oncology 28 (10) (2021)
Kathleen Iles, Stephanie M Downs-Canner
ASO Author Reflections: Use of Axillary Staging Surgery Before Systemic Therapy in Breast Cancer Highlights a Need for Implementation Science in Surgery. Annals of surgical oncology (2021)
Jeffrey E Johnson, Paula D Strassle, Guilherme C de Oliveira, Chris B Agala, Philip Spanheimer, Kristalyn Gallagher, David Ollila, Hyman Muss, Stephanie M Downs-Canner
Suboptimal therapy following breast conserving surgery in triple-negative and HER2-positive breast cancer patients. Breast cancer research and treatment 189 (2) (2021)
Stephanie M Downs-Canner, Charles E Gaber, Raphael J Louie, Paula D Strassle, Kristalyn K Gallagher, Hyman B Muss, David W Ollila
Nodal positivity decreases with age in women with early-stage, hormone receptor-positive breast cancer. Cancer 126 (6) (2019)